| Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? KA Hazlewood, SD Brouse, WD Pitcher, RG Hall The American journal of medicine 123 (2), 182. e1-182. e7, 2010 | 186 | 2010 |
| Atazanavir for the treatment of human immunodeficiency virus infection AJ Busti, RG Hall, DM Margolis Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24 (12 …, 2004 | 139 | 2004 |
| Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin AJ Busti, AM Bain, RG Hall, RG Bedimo, RD Leff, C Meek, R Mehvar Journal of cardiovascular pharmacology 51 (6), 605-610, 2008 | 130 | 2008 |
| Treatment of active pulmonary tuberculosis in adults: current standards and recent advances: insights from the Society of Infectious Diseases Pharmacists RG Hall, RD Leff, T Gumbo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (12 …, 2009 | 102 | 2009 |
| Clinical and microbiologic analysis of a hospital's extended‐spectrum β‐lactamase‐producing isolates over a 2‐year period DS Burgess, RG Hall, JS Lewis, JH Jorgensen, JE Patterson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (10 …, 2003 | 101 | 2003 |
| Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections C Giuliano, KK Haase, R Hall Expert review of anti-infective therapy 8 (1), 95-106, 2010 | 92 | 2010 |
| Multicenter evaluation of vancomycin dosing: emphasis on obesity RG Hall II, KD Payne, AM Bain, AP Rahman, ST Nguyen, SA Eaton, ... The American journal of medicine 121 (6), 515-518, 2008 | 84 | 2008 |
| In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae DS Burgess, RG Hall II Diagnostic microbiology and infectious disease 49 (1), 41-46, 2004 | 81 | 2004 |
| Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people RG Hall, MA Swancutt, T Gumbo Antimicrobial agents and chemotherapy 55 (11), 5107-5112, 2011 | 65 | 2011 |
| Infectious Diseases: Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus DO Maclayton, RG Hall Annals of Pharmacotherapy 41 (2), 235-244, 2007 | 64 | 2007 |
| Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths RG Hall, MA Swancutt, C Meek, R Leff, T Gumbo Antimicrobial agents and chemotherapy 57 (5), 2259-2264, 2013 | 55 | 2013 |
| Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia … RG Hall, KA Hazlewood, SD Brouse, CA Giuliano, KK Haase, CR Frei, ... BMC Pharmacology and Toxicology 14, 1-6, 2013 | 52 | 2013 |
| Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people RG Hall, MA Swancutt, C Meek, RD Leff, T Gumbo Antimicrobial agents and chemotherapy 56 (3), 1502-1507, 2012 | 44 | 2012 |
| Dosing considerations for obese patients receiving cancer chemotherapeutic agents RG Hall, GW Jean, M Sigler, S Shah Annals of Pharmacotherapy 47 (12), 1666-1674, 2013 | 40 | 2013 |
| In vitro evaluation of the activity of two doses of levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa DS Burgess, RG Hall, TC Hardin Diagnostic microbiology and infectious disease 46 (2), 131-137, 2003 | 40 | 2003 |
| Dosing of antifungal agents in obese people KD Payne, RG Hall Expert review of anti-infective therapy 14 (2), 257-267, 2016 | 39 | 2016 |
| Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing MD Lopes-Serrao, SMG Ussery, RG Hall, SR Shah Journal of Oncology Practice 7 (1), 13-17, 2011 | 39 | 2011 |
| Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study RG Hall, CA Giuliano, KK Haase, KA Hazlewood, CR Frei, NA Forcade, ... BMC Infectious Diseases 12, 1-5, 2012 | 38 | 2012 |
| Dosing of antibacterial agents in obese adults: does one size fit all? KD Payne, RG Hall Expert Review of Anti-infective Therapy 12 (7), 829-854, 2014 | 36 | 2014 |
| Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind A Arnold, SD Brouse, WD Pitcher, RG Hall Journal of intensive care medicine 25 (5), 259-270, 2010 | 29 | 2010 |
Carlos Alvarez, PharmD, MSc, MSCS,...Associate Professor, Texas Tech University Health Sciences Center在 ttuhsc.edu 的电子邮件经过验证
